ExodusPoint Capital Management’s Akcea Therapeutics Inc AKCA Stock Holding History

ExodusPoint Capital Management’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-13,111	Closed	-$238K	–	2578
2020 Q3	$238K	Sell	13,111 -33,425	-72%	-$474K	﹤0.01%	1395
2020 Q2	$638K	Buy	+46,536	New	+$718K	0.02%	963
2020 Q1	–	Sell	-11,720	Closed	-$199K	–	1872
2019 Q4	$199K	Buy	+11,720	New	+$218K	﹤0.01%	1341

ExodusPoint Capital Management's AKCA Position: Q4 2020 in Review

ExodusPoint Capital Management sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 13,111 shares — an estimated $238K sold.

ExodusPoint Capital Management first reported a position in AKCA in Q4 2019 and held it in 3 quarters. The position peaked at $638K in Q2 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

ExodusPoint Capital Management reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
ExodusPoint Capital Management sold 13,111 Akcea Therapeutics Inc shares in Q4 2020, an estimated $238K.
ExodusPoint Capital Management first reported a position in Akcea Therapeutics Inc in Q4 2019 and held it in 3 quarters.
ExodusPoint Capital Management's Akcea Therapeutics Inc position peaked at $638K in Q2 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.